Erratum in «High rate of virologic supression with darunavir/ritonavir plus optimazed background therapy among highly antiretroviral-experienced HIV-infected patients: results of a prospective cohort study in São Paulo, Brazil

Vidal, José Ernesto; Song, Alice Tung Wan; Matos, Maria Laura; Bartmann, Daniel; Anjos, Guilherme dos; Érique José Peixoto de Miranda; Freitas, Ângela Carvalho; Mirian de Freitas Dalben; Santana, Claudinei; Segurado, Aluísio Cotrim; Cláudia Cortese Barreto; Hernández, Adrián Vladimir.
Braz. j. infect. dis ; 17(3): 387-387, May-June 2013.
Artículo en Inglés | SES-SP, SESSP-IIERPROD, SES-SP | ID: biblio-1061611

Documentos relacionados

  1. Degradants of Tenofovir Disoproxil Fumarate Under Forced Yet Mild Thermal Stress: Isolation, Comprehensive Structural Elucidation, and Mechanism.
  2. Early Initiation of Antiretroviral Therapy Preserves the Metabolic Function of CD4+ T Cells in Subtype C Human Immunodeficiency Virus 1 Infection.
  3. Clinical Profile and Determinants of Loss to Follow-Up in Patients Enrolled in an Urban Antiretroviral Treatment Programme in Northwestern Nigeria.
  4. HIV drug resistance in the era of contemporary antiretroviral therapy: A clinical perspective.
  5. The Incidence and Severity of Drug Interactions Before and After Antiretroviral Therapy Simplification in Treatment-Experienced Patients With HIV Infection.
  6. Fusing trial data for treatment comparisons: Single vs multi-span bridging.
  7. [HIV. Long-acting treatment : clinical experience, limits and future perspectives].
  8. Predictors of antiretroviral treatment failure to the first line therapy: a cross-sectional study among Iranian HIV-positive adults.
  9. Barriers and enabling structural forces affecting access to antiretroviral therapy in Nigeria.
  10. Antiretroviral Initiation at ≥800 CD4+ Cells/mm3 Associated With Lower Human Immunodeficiency Virus Reservoir Size.